VTR
35
4
HPE
40
-2
HCA
48
6
ADI
62
5
GOOG
65
-4
JCI
45
4
MA
46
2
YUM
33
-2
KMX
47
7
HES
61
2
GT
41
-2
PFG
36
3
ICE
45
3
HD
37
2
VRTX
49
3
STT
59
14
GOOGL
54
-4
GIS
34
2
MAS
42
2
ADP
66
4
VTR
35
4
HPE
40
-2
HCA
48
6
ADI
62
5
GOOG
65
-4
JCI
45
4
MA
46
2
YUM
33
-2
KMX
47
7
HES
61
2
GT
41
-2
PFG
36
3
ICE
45
3
HD
37
2
VRTX
49
3
STT
59
14
GOOGL
54
-4
GIS
34
2
MAS
42
2
ADP
66
4
Financhill
Back

First Citizens BancShares Vs. Crinetics Pharmaceuticals Industry Stock Comparison

Sell
46

FCNCA
First Citizens BancShares

Last Price:
$2,071.74
Seasonality Move:
3.77%
Sell
8

CRNX
Crinetics Pharmaceuticals

Last Price:
$40.59
Seasonality Move:
-9.08%
Sell
46
First Citizens BancShares (FCNCA) is a Sell

Is First Citizens BancShares a Buy, Sell or Hold?

  • The current First Citizens BancShares [FCNCA] share price is $2,094.00. The Score for FCNCA is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • FCNCA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
8
Crinetics Pharmaceuticals (CRNX) is a Sell

Is Crinetics Pharmaceuticals a Buy, Sell or Hold?

  • The current Crinetics Pharmaceuticals [CRNX] share price is $48.50. The Score for CRNX is 8, which is 84% below its historic median score of 50, and infers higher risk than normal.
  • CRNX is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

FCNCA Stock Price Chart

What is First Citizens BancShares's stock price today?

  • The First Citizens BancShares share price today is $2,094.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FCNCA is experiencing selling pressure, which indicates risk of future bearish movement.

CRNX Stock Price Chart

What is Crinetics Pharmaceuticals's stock price today?

  • The Crinetics Pharmaceuticals share price today is $48.50
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRNX is experiencing slight selling pressure.

FCNCA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -8.29 Sell
Relative Strength Index (14 RSI): 44.28 Sell
Chaikin Money Flow: -30724 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2084.9 - 2170.78) Sell
Bollinger Bands (100): (1907.74 - 2181.68) Buy

CRNX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.69 Sell
Relative Strength Index (14 RSI): 34.32 Sell
Chaikin Money Flow: -235099 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (51.1 - 56.94) Sell
Bollinger Bands (100): (51.5 - 57.46) Sell

FCNCA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2121.52 Sell
20-day SMA: 2112.18 Sell
50-day SMA: 2141.31 Sell
200-day SMA: 1890.96 Buy
8-day EMA: 2120.05 Sell
20-day EMA: 2128.98 Sell
50-day EMA: 2114.85 Sell
200-day EMA: 1905.12 Buy

CRNX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 50.85 Sell
20-day SMA: 53.18 Sell
50-day SMA: 55.63 Sell
200-day SMA: 51.03 Sell
8-day EMA: 50.82 Sell
20-day EMA: 52.67 Sell
50-day EMA: 54.22 Sell
200-day EMA: 49.96 Sell

First Citizens BancShares Earnings Growth & FCNCA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $6.44 per share, a decrease next quarter of $0.00 per share, a decrease this year of $26.51 per share, and an increase next year of $24.68 per share.

Crinetics Pharmaceuticals Earnings Growth & CRNX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.47 per share.

First Citizens BancShares Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Crinetics Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):